MAX Chat
Share chart Illumina
Extended chart
Simple chart
About Illumina
Компания Illumina, Inc., основана в апреле 1998 года, занимается разработкой, производством и внедрением систем анализа генетического разнообразия и биологических функций. Illumina производит линейку продуктов и услуг для секвенирования, генотипирования и изучения экспрессии генов.Main settings
IPO date
2000-07-28
ISIN
US4523271090
Industry
Life Sciences Tools & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 4.86 | 3 |
| P/BV | 8.95 | 1 |
| P/E | 39.92 | 4 |
Efficiency
| Title | Value | Grade |
| ROA | -14.9 | 0 |
| ROE | -30.13 | 0 |
| ROIC | 6.96 | 2 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -3.62 | 10 |
| Debt/Ratio | 0.416 | 10 |
| Debt/Equity | 1.66 | 7 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 34.94 | 5 |
| Yield Ebitda, % | -225 | 0 |
| Yield EPS, % | -273.63 | 0 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 99.25 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 99.27 $ | 99.25 $ | 99.25 $ | -0.0201 % | 0 % | 0 % |
| Month | 90.49 $ | 90.26 $ | 100.8 $ | +9.68 % | 0 % | 0 % |
| Three month | 75.76 $ | 71.2 $ | 100.8 $ | +31.01 % | 0 % | 0 % |
| Half a year | 84.65 $ | 70.3 $ | 141.31 $ | +17.25 % | 0 % | 0 % |
| Year | 140.66 $ | 70.3 $ | 155.15 $ | -29.44 % | 0 % | 0 % |
| 3 years | 209.68 $ | 70.3 $ | 245.45 $ | -52.67 % | 0 % | 0 % |
| 5 years | 392.73 $ | 70.3 $ | 524.84 $ | -74.73 % | 0 % | 0 % |
| 10 years | 128.04 $ | 70.3 $ | 524.84 $ | -22.49 % | 0 % | 0 % |
| Year to date | 94.2 $ | 70.3 $ | 144.22 $ | +5.36 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Global X Telemedicine & Digital Health ETF Registered | 4.01425 | 0.4251 | 0.68 |
| Future Tech ETF | 2.02764 | 479.5 | 0.35 |
| Principal Healthcare Innovators ETF | 2.02764 | -3.92 | 0.35 |
| IQ Engender Equality ETF | 1.49781 | 3.37 | 0.45 |
| Pacer BioThreat Strategy ETF | 0.71622 | 2.4 | 0.7 |
| Syntax Stratified MidCap ETF | 0.45703 | -0.3413 | 0.35 |
| iShares Morningstar Mid-Cap Growth ETF | 0.38685 | 450.65 | 0.06 |
| iShares Morningstar Mid-Cap ETF | 0.19271 | 245.03 | 0.04 |
| Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.14325 | 7.59 | 0.68 |
| iShares Morningstar Large-Cap Growth ETF | 0.08548 | 245.22 | 0.04 |
| iShares Morningstar Large-Cap ETF | 0.04135 | 186.3 | 0.03 |
| JPMorgan U.S. Aggregate Bond ETF | 0.03 | 0.5961 | 0.07 |
| Columbia U.S. ESG Equity Income ETF | 0.02743 | -4.51 | 0.35 |
| 0.9 | 124.02 | 0.32 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Stephanie Campos | President | N/A | |
| Mr. Charles E. Dadswell Esq. | Senior VP & General Counsel | 1.06M | 1959 (66 years) |
| Ms. Carissa L. Rollins | Chief Information Officer | N/A | 1970 (55 years) |
| Dr. Steven Barnard Ph.D. | Chief Technology Officer | N/A | |
| Ms. Sallilyn Schwartz | Vice President of Investor Relations | N/A | |
| Mr. Jacob Thaysen Ph.D. | CEO & Director | N/A | 1975 (50 years) |
| Mr. Ankur Dhingra | Chief Financial Officer | 1976 (49 years) | |
| Mr. Kevin Carl Pegels | Chief of Global Operations | 1968 (57 years) | |
| Mr. Scott Ericksen | VP & Chief Accounting Officer | 1973 (52 years) | |
| Mr. Jakob Wedel | Chief Strategy & Corporate Development Officer and CEO Chief of Staff |
About company
Address: United States, San Diego, 5200 Illumina Way - Open in google maps, Open in yandex maps
Website: http://www.illumina.com
Website: http://www.illumina.com
